Assessing a broader user base for new HCV drug.

Suppr

超能文献

作者信息

Sekkides Onisillos

出版信息

Lancet Infect Dis. 2015 Apr;15(4):383. doi: 10.1016/S1473-3099(15)70119-2.

DOI:10.1016/S1473-3099(15)70119-2

PMID:25809898

Abstract

摘要

相似文献

Assessing a broader user base for new HCV drug.

Lancet Infect Dis. 2015 Apr;15(4):383. doi: 10.1016/S1473-3099(15)70119-2.

[Interferon free recovery for almost all patients].

MMW Fortschr Med. 2015 Mar 5;157(4):71. doi: 10.1007/s15006-015-2780-4.

A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.

Med Lett Drugs Ther. 2014 Nov 10;56(1455):111-2.

Anti-HCV for porphyria cutanea tarda.

Dermatol Ther. 2017 May;30(3). doi: 10.1111/dth.12466. Epub 2017 Jan 30.

Therapy for hepatitis C--the costs of success.

N Engl J Med. 2014 Apr 17;370(16):1552-3. doi: 10.1056/NEJMe1401508. Epub 2014 Apr 11.

Are we hopefully very close to the end of HCV?

Turk J Gastroenterol. 2014 Apr;25(2):230-1. doi: 10.5152/tjg.2014.0009.

Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.

J Antimicrob Chemother. 2017 Oct 1;72(10):2955-2958. doi: 10.1093/jac/dkx222.

Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.

Pediatr Infect Dis J. 2016 Dec;35(12):1373. doi: 10.1097/INF.0000000000001336.

Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.

Ann Intern Med. 2018 May 1;168(9):678-680. doi: 10.7326/L17-0613. Epub 2018 Jan 16.

Drug-Drug Interactions in Patients Co-infected With HCV and HIV.

JAMA. 2015 Jul 14;314(2):186. doi: 10.1001/jama.2015.6618.

引用本文的文献

Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1Patients Treated by Pegylated Interferon and Ribavirin.

Iran J Pathol. 2016 Summer;11(3):216-221.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Assessing a broader user base for new HCV drug.

Lancet Infect Dis. 2015 Apr;15(4):383. doi: 10.1016/S1473-3099(15)70119-2.

[Interferon free recovery for almost all patients].

MMW Fortschr Med. 2015 Mar 5;157(4):71. doi: 10.1007/s15006-015-2780-4.

A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.

Med Lett Drugs Ther. 2014 Nov 10;56(1455):111-2.

Anti-HCV for porphyria cutanea tarda.

Dermatol Ther. 2017 May;30(3). doi: 10.1111/dth.12466. Epub 2017 Jan 30.

Therapy for hepatitis C--the costs of success.

N Engl J Med. 2014 Apr 17;370(16):1552-3. doi: 10.1056/NEJMe1401508. Epub 2014 Apr 11.

Are we hopefully very close to the end of HCV?

Turk J Gastroenterol. 2014 Apr;25(2):230-1. doi: 10.5152/tjg.2014.0009.

Resolution of porphyria cutanea tarda in HIV and mixed HCV coinfection after direct-acting antiviral (DAA) therapy.

J Antimicrob Chemother. 2017 Oct 1;72(10):2955-2958. doi: 10.1093/jac/dkx222.

Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.

Pediatr Infect Dis J. 2016 Dec;35(12):1373. doi: 10.1097/INF.0000000000001336.

Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.

Ann Intern Med. 2018 May 1;168(9):678-680. doi: 10.7326/L17-0613. Epub 2018 Jan 16.

Drug-Drug Interactions in Patients Co-infected With HCV and HIV.

JAMA. 2015 Jul 14;314(2):186. doi: 10.1001/jama.2015.6618.

引用本文的文献

Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1Patients Treated by Pegylated Interferon and Ribavirin.

Iran J Pathol. 2016 Summer;11(3):216-221.